Physicians, pharmaceutical sales representatives, and the cost of prescribing

被引:109
|
作者
Caudill, TS
Johnson, MS
Rich, EC
McKinney, WP
机构
[1] VET AFFAIRS MED CTR,LEXINGTON,KY
[2] UNIV KENTUCKY,DEPT BEHAV SCI,LEXINGTON,KY
[3] UNIV LOUISVILLE,DEPT MED,HLTH SCI CTR,LOUISVILLE,KY 40292
关键词
D O I
10.1001/archfami.5.4.201
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the influence of primary care physicians' attitudes toward and use of information provided by pharmaceutical representatives on prescribing costs in ambulatory practice. Design: A mailed questionnaire collected information about physician demographic and practice characteristics and attitudes toward and use of information provided by pharmaceutical representatives. Participants: Kentucky physicians practicing primary care adult medicine (family medicine, general practice, general medicine; n=1603). Main Outcome Measure: Relative cost of prescribing, based on physician responses to treatment choices for ambulatory clinical scenarios in primary care. A multivariable regression model assessed predictive relationships between independent variables and prescription costs. Results: Four hundred forty-six returned questionnaires were suitable for analysis. No significant differences were noted in age, gender, days worked per week, or years since graduation between responders and a sample of nonresponders. A significant positive correlation was found between physician cost of prescribing and perceived credibility, availability, applicability, and use of information provided by pharmaceutical representatives (P<.01, Pearson's Product-Moment Correlation Coefficient). Physicians in academic or hospital-based practice settings had significantly lower prescribing costs than physicians in nonacademic and nonhospital practices (P=.001, analysis of variance). Frequency of use of information provided by pharmaceutical representatives (P=.01, multiple linear regression) and the group practice setting (P=.02, multiple linear regression) remained significant, independent positive predictors of cost in the multivariable regression model. Conclusions: Frequency of use of information provided by pharmaceutical representatives and the group practice, nonacademic and nonhospital setting may be associated with increased primary care physician prescribing costs.
引用
下载
收藏
页码:201 / 206
页数:6
相关论文
共 50 条
  • [31] INFLUENCE OF PHARMACEUTICAL SALES REPRESENTATIVES ON THE FORMULARY SYSTEM
    HOPPE, SA
    GORAHARPER, ML
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (14) : 1549 - 1551
  • [32] Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives
    Clauson, Kevin A.
    Khanfar, Nile M.
    Polen, Hyla H.
    Gibson, Florencetta
    JOURNAL OF CLINICAL NURSING, 2009, 18 (02) : 228 - 233
  • [33] Encounters with pharmaceutical sales representatives among practicing internists
    Ferguson, RP
    Rhim, E
    Belizaire, W
    Egede, L
    Carter, K
    Lansdale, T
    AMERICAN JOURNAL OF MEDICINE, 1999, 107 (02): : 149 - 152
  • [34] THE ACCURACY OF DRUG INFORMATION FROM PHARMACEUTICAL SALES REPRESENTATIVES
    ZIEGLER, MG
    LEW, P
    SINGER, BC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (16): : 1296 - 1298
  • [35] Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
    Spurling, Geoffrey K.
    Mansfield, Peter R.
    Montgomery, Brett D.
    Lexchin, Joel
    Doust, Jenny
    Othman, Noordin
    Vitry, Agnes I.
    PLOS MEDICINE, 2010, 7 (10)
  • [36] Physicians, pharmaceutical representatives, and patients: Who really benefits?
    Westfall, JM
    JOURNAL OF FAMILY PRACTICE, 2000, 49 (09): : 817 - 819
  • [37] General practitioners and pharmaceutical sales representatives: Quality improvement research
    Spurling, Geoffrey
    Mansfield, Peter
    QUALITY & SAFETY IN HEALTH CARE, 2007, 16 (04): : 266 - 270
  • [38] INVOLVEMENT OF PHARMACY FACULTY IN THE DEVELOPMENT OF POLICIES FOR PHARMACEUTICAL SALES REPRESENTATIVES
    BUCCI, KK
    FREY, KA
    JOURNAL OF FAMILY PRACTICE, 1992, 34 (01): : 49 - 52
  • [39] NATIONAL SURVEY OF HOSPITAL POLICIES ON PHARMACEUTICAL SALES REPRESENTATIVES ACTIVITIES
    THOMAS, J
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1987, 44 (06): : 1334 - 1340
  • [40] PHYSICIAN CONTACTS WITH PHARMACEUTICAL SALES REPRESENTATIVES IN MEDICINE TEACHING PROGRAMS
    RICH, E
    LURIE, N
    MEYER, J
    SCHIEDERMAYER, D
    MCKINNEY, P
    CLINICAL RESEARCH, 1988, 36 (03): : A349 - A349